Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02270463
Title SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Stemline Therapeutics, Inc.
Indications

acute myeloid leukemia

Therapies

Tagraxofusp-erzs

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST